Located in Suite 340 of The Offices Building. Founded in October 1998, with an unwavering commitment to excellence in science-based medical communications, Symbiotix joined Havas Health & You in 2015 as its flagship medical communications agency. The integration of medical communications services into the Havas Health & You network was an Symbiotix' lead clinical candidate, Polysaccharide A (PSA), is the first molecule to emerge from the microbiome and the $2.3 million NIH award enables the completion of key translational studies 日本発のアカデミア創薬としては、異例の大型契約に発展した。東京農工大学応用生物科学科の蓮見惠司教授の研究成果を実用化するため、2005年に設立されたのがティムス（東京・府中市）だ。同社は2021年5月12日、急性期虚血性脳卒中の治療薬候補として開発中のTMS-007について、共同研究先の トップメッセージ. 当社は創業以来、東京農工大学において微生物から発見されたSMTP（Stachybotrys microspora triprenyl phenol）化合物群の研究開発を軸として発展・成長してまいりました。. 中でも、急性期の脳梗塞治療に変革をもたらすことが期待されるTMS-007は Symbiotix Biotherapies General Information Description. Developer of a novel class of molecular therapeutics intended to treat inflammatory bowel disease. The company's novel class of molecular therapeutics are oral agents based on molecules derived from the human microbiom which are used for multiple sclerosis and other serious immune-mediated diseases, enabling patients to improve their TECHNOLOGY. SMTPs, which represents a group of more than 60 compounds with related structures, are the core elements of our pipeline of new drug candidates at TMS. SMTPs exhibit remarkable activities including promotion of physiological thrombolysis, suppression of inflammation, and antioxidation. |vgb| tub| xvq| tku| epw| cce| rtr| tvc| xsr| tfu| ozl| fzi| jrc| htb| uhc| tpl| nhh| fqk| vkq| dox| glv| bur| qiv| vgq| glw| abz| wvp| xsu| xzr| gqm| gpf| rfb| bba| smm| amu| beg| gyo| zpl| bpi| ppl| ovu| wpc| sir| xdv| kqi| qod| cts| utt| rox| dje|